Overview: Filaria Antigen TestIntroduction: The Filaria Antigen Test detects filaria antigens, confirming active parasitic infection causing swelling or fever. Following 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in serology for patients with suspected active filariasis.
Other Names: Filaria Antigen Assay, Active Filariasis Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Filaria antigen testing began in the 1990s with parasitic research. Immunoassays emerged in the 2000s, improving accuracy for active infection detection.
Purpose: Confirms active filarial infection, guides antiparasitic therapy, and monitors antigens in patients with swelling or fever.
Test Parameters: 1. Filaria Antigen
Pretest Condition: No fasting required. Collect serum, whole blood, or saliva at any time. Report symptoms like swelling or fever, and list travel to endemic areas.
Specimen: 2-5 mL serum (SST), 2-5 mL whole blood (EDTA), or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document swelling, fever, or travel to filaria-endemic areas. Include current medications, especially antiparasitics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiparasitic therapy.
Procedural Considerations: Uses an immunoassay to detect filaria antigens. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Low antigen levels or improper storage can cause false negatives. Cross-reactivity may cause false positives.
Clinical Significance: Positive antigen results confirm active filarial infection, prompting antiparasitic therapy. Negative results may require repeat testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation.
Additional Supporting Tests: Filaria IgG/IgM, microscopy, or imaging to confirm filariasis.
Test Limitations: False negatives may occur with low antigen levels. Results require clinical correlation.
References: IDSA Parasitic Guidelines, 2023; Clinical Infectious Diseases, Nutman TB, 2022.
